17 April 2018Biotechnology

Shire to sell oncology business for $2.4bn

Biotech company Shire has revealed plans to sell its oncology business for $2.4 billion to France-based Servier.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

More on this story

Asia-Pacific
3 April 2018   Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018   Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018   Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.